← Leaderboards
William Goodman
University Of California Los Angeles
$829,064
Attributed
$829,064
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$829,064 · 2
By mechanism
M01$829,064 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Olaf Schneewind$43,068,570
- Isidro B. Benjamin Salusky$22,568,917
- Robert L Modlin$53,861,964
- George Sachs$7,723,675
- Jonathan D. Kaunitz$4,687,586
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHyperparathyroidismHuman SubjectDiuresisDosageDrug Adverse EffectDrug Screening /EvaluationEndocrine Disorder ChemotherapyHormone Regulation /Control MechanismHuman Therapy EvaluationParathyroid GlandParathyroid HormonesPathologic ProcessBiomimeticsSecretionCalciumChronic Renal Failure
Grant awards (4)
DIURNAL AND SECRETION BY THE PARATHYROID GLANDS IN CHRONIC RENAL INSUFFICIENCY$207,266
M01 · FY2001 · RR
DIURNAL AND SECRETION BY THE PARATHYROID GLANDS IN CHRONIC RENAL INSUFFICIENCY$207,266
M01 · FY2001 · RR
SINGLE &MULTIPLE DOSES OF AN ORAL CALCIMIMETIC AGENT IN HYPERPARATHYROIDISM$207,266
M01 · FY2001 · RR
SINGLE &MULTIPLE DOSES OF AN ORAL CALCIMIMETIC AGENT IN HYPERPARATHYROIDISM$207,266
M01 · FY2001 · RR